Fingerprint
Dive into the research topics of 'Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically